SynthesisScientific reports2025
Comprehensive safety analysis of adverse events associated with eptinezumab in migraine treatment.
Junchen Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it